ArticleCureus2025
Comparison of T Cell Immune Responses Against SARS-CoV-2 Using QuantiFERON SARS-CoV-2 Assay Versus Peripheral Blood Mononuclear Cells Analysis by Flow Cytometry.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction COVID-19 continues to have a global impact with the emergence of the latest variant of interest: JN.01, the commonest worldwide. While most studies on immune responses against SARS-CoV-2 are based on the evaluation of the humoral arm, data regarding cell-mediated immune responses are sparse and still emerging. Materials and methods A sample of 51 study participants was subjected to an interferon gamma release assay (QuantiFERON SARS-CoV-2). T cell (CD4+ or CD8+) responses to SARS-CoV-2 were characterized in a subset of 10 participants using multicolor flow cytometry. Results Thirty-seven participants had positive results for the anti-SARS-CoV-2 IgG antibody, and QuantiFERON SARS-CoV-2 assay antigen 1 and 2 positivity was observed in two participants only. In comparison, upon analyzing peripheral blood mononuclear cells using flow cytometry in a subset of 10 participants negative for the QuantiFERON SARS-CoV-2 assay, five had positive T cell immune responses. Conclusion Our study demonstrates higher positivity for T cell response among 10 adult individuals when tested using flow cytometry for peripheral blood mononuclear cell analysis as compared to the interferon gamma release assay. Such data on immune responses to SARS-CoV-2 will be useful in developing predictive B- and T cell-based immune correlates and algorithms for personalized risk assessment and clinical response evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.